/PRNewswire/ Diadem Srl today announced CE IVD certification for its AlzoSure® Predict prognostic blood test for the early prediction of Alzheimer s disease.
FDA Grants Breakthrough Device Designation to Diadem's AlzoSure® Predict Prognostic Blood Test for the Early Prediction of Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace
A new blood test that identifies a variant of the protein P53 appears to predict Alzheimer s disease progression up to 6 years in advance of a clinical diagnosis, early research suggests.
/PRNewswire/ Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer s disease (AD), presented data showing that.